Get more information on Radiotherapy Market - Request Free Sample Report
The Radiotherapy Market Size was valued at USD 7.01 Billion in 2023, and is expected to reach USD 11.18 Billion by 2032, and grow at a CAGR of 5.54%.
The global market of radiotherapy experiencing rapid growth due to the increasing rate of cancer all over the world. Thus, according to the statistics of the World Health Organization, cancer is the second biggest killer globally. Furthermore, in 2023, the U.S. National Cancer Institute reported a 7% rise in federal funding for cancer research and treatments. More specifically, over USD 8.4 billion has been allocated to support radiotherapy advancement. Moreover, in Europe, the European Commission has increased the Cancer Mission budget up to Euro 1.2 billion in the framework of the “Beating Cancer Plan”.
In response to that, healthcare systems globally have started to implement radiotherapy technologies at an increasingly high rate. However, the other triggers that propel the market forward include the rising awareness of radiotherapy efficiency and a growing number of cancer patients worldwide (more than 19.3 million new cases in 2023). Moreover, the technological advancements in the field, namely, intensity-modulated radiation therapy and stereotactic body radiotherapy, have made the treatments more accurate and relevant, leading to better patient outcomes as well.
Key Drivers:
The Growing Number of Cancer Patients Worldwide Drives Demand for Advanced Radiation Therapies.
Increased Adoption of Personalized Radiation Therapy Enhances Treatment Outcomes and Opens New Market Avenues.
Restraints:
Expensive Equipment and Treatment Procedures Limit Access, Especially in Developing Regions.
Concerns Over Potential Radiation Side Effects Restrict Patient Acceptance.
Opportunity:
Expanding Healthcare Infrastructure in Asia-Pacific and Latin America Presents Growth Opportunities for Radiation Therapy.
Increasing Innovations in Radiation Therapy, Such as Image-Guided Techniques, are Improving Treatment Precision.
By Type
In 2023, EBRT dominated the radiotherapy market, with a 55% total share. The procedure’s share of the market was extensive due to its high use in several types of cancers. Breast, prostate, and lung cancers are the most common types of cancer aside from skin cancer. According to the CDC, breast cancer remains the most common among women, with the same applying to prostate cancer among men. The procedure continues to be the most used due to government investment. In 2023, the federal government spent approximately USD 1.1 billion on research into breast cancer. EBRT is used on breast cancer patients to reduce the need for surgical services. The treatment is non-invasive, irrespective of advancements in radiation, such as image-guided radiation therapy.
The procedure has become widely employed across Europe by the emergence of the HERA agreement on expanding healthcare technology investments by governmental entities. EBRT is used to provide the most significant standard of care over varying types of oncology. This conclusion was based on the fact that more incidences of cancer are being documented since more populations are now aware of the illness. These people are thus encouraged to own types of treatment that are simple and will target the exact affected area of the body. Additionally, the treatments remain profitable for healthcare providers, resulting in diseases becoming less fatal and ensuring patients survive longer.
Get Customized Report as per your Business Requirement - Request For Customized Report
By End-User
Hospitals as an end-user segment held the largest share in the radiotherapy market in 2023, accounting for over 60% of the market share. It is considered the largest market segment for radiotherapy because hospitals have considerable infrastructure, technology, and access to skilled health professionals. According to the U.S. National Cancer Institute, about 75% of all radiotherapy procedures are done in hospitals due to substantial facilities and availability of radiotherapy machines such as linear accelerators. Additionally, public hospital systems are heavily supported by their governments. For instance, the U.K. government, in 2023, provided an additional £5.4 billion to its National Health Service to improve cancer treatment, including radiotherapy centers.
The World Bank and World Health Organization launched initiatives to boost the hospital infrastructure and upgrade radiotherapy in low and middle-income countries. Research institutes and ambulatory therapy centers are the fastest-growing segments, but hospital centers currently have an advantage with newer machines and an established patient population and referral system.
In the year 2023, North America was the leading region with 40% of the total market share in the global radiotherapy market. The comprise to the leadership of the region was attributed to its high cancer prevalence, good government support, and the availability of modern healthcare. In the U.S. where cancer spending care was expected to rise to USD 246 billion by the end of the year, The National Institutes of Health and the U.S. National Cancer Institute proceeded to expend their energy towards supporting the implementation of sophisticated technologies in the treatment of the disease. Consequently, the U.S. Food and Drug Administration in the same year promptly approved various innovative radiotherapy devices that accelerated the growth of the market.
Besides, Canada affected the leadership of the region through the allocation of more than CAD 500 million to the cause of health innovation. The amount was focused on facilitating the improvement of cancer treatment therapies such as radiotherapy under the country’s 2023 health budget. Furthermore, North America is focused on the adoption of leading technologies in the treatment of diseases such as proton therapy. The region asserted its earlier claim of being the leading geographical market for radiotherapy based on its well-set government support and a good country healthcare system. Other competing regions such as Europe and the Asia Pacific are rapidly taking the competitive nature in boosting the health systems, but it would be very difficult to overpower North America based on the availability of comprehensive treatment mechanisms.
The key market players are Canon Medical Systems Corporation, Accuray Incorporated, Elekta, GE Healthcare, ViewRay Technologies, Inc., Isoray Inc., Mevion Medical Systems, Siemens Healthineers AG, Hitachi, Ltd., ALCEN (PMB) and other players.
In May 2023: GE HealthCare invested in three radiotherapy machines comprising intelligent machines (IRT), auto segmentation in addition to an updated magnetic radiation suite referred to as AIR open coil suite.
In February 2023: RefelXion Medical was granted the United States Food and Drug Administration approval of SCINTIC biology-guided radiotherapy for early and late treatment of cancer.
|
Report Attributes |
Details |
|---|---|
|
Market Size in 2023 |
US$ 7.01 Billion |
|
Market Size by 2032 |
US$ 11.18 Billion |
|
CAGR |
CAGR of 5.54% From 2024 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2020-2022 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
•By Type (External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy) |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
|
Company Profiles |
Canon Medical Systems Corporation, Accuray Incorporated, Elekta, GE Healthcare, ViewRay Technologies, Inc., Isoray Inc., Mevion Medical Systems, Siemens Healthineers AG, Hitachi, Ltd., ALCEN (PMB) and other players |
|
Key Drivers |
•The Growing Number of Cancer Patients Worldwide Drives Demand for Advanced Radiation Therapies. |
|
RESTRAINTS |
•Expensive Equipment and Treatment Procedures Limit Access, Especially in Developing Regions. |
Ans: The Radiotherapy Market is expected to grow at 5.54% CAGR from 2024 to 2032.
Ans: According to our analysis, the Radiotherapy Market is anticipated to reach USD 11.18 billion by 2032.
Ans: The prominent players in the Radiotherapy Market are Canon Medical Systems Corporation, Accuray Incorporated, Elekta, GE Healthcare, ViewRay Technologies, Inc., Isoray Inc., Mevion Medical Systems, Siemens Healthineers AG, Hitachi, Ltd., ALCEN (PMB) and Other players
Ans: In terms of type, the external beam radiotherapy market was dominant in 2023.
Ans: Yes, you may request customization based on your company's needs.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Type and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Type Benchmarking
6.3.1 Type specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Type launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Radiotherapy Market Segmentation, by Type
7.1 Chapter Overview
7.2 External Beam Radiation Therapy
7.2.1 External Beam Radiation Therapy Market Trends Analysis (2020-2032)
7.2.2 External Beam Radiation Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Internal Radiation Therapy
7.3.1 Internal Radiation Therapy Market Trends Analysis (2020-2032)
7.3.2 Internal Radiation Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Systemic Radiation Therapy
7.4.1 Systemic Radiation Therapy Market Trends Analysis (2020-2032)
7.4.2 Systemic Radiation Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Radiotherapy Market Segmentation, by Application
8.1 Chapter Overview
8.2 Skin & Lip Cancer
8.2.1 Skin & Lip Cancer Market Trends Analysis (2020-2032)
8.2.2 Skin & Lip Cancer Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Breast Cancer
8.3.1 Breast Cancer Market Trends Analysis (2020-2032)
8.3.2 Breast Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Prostate Cancer
8.4.1 Prostate Cancer Market Trends Analysis (2020-2032)
8.4.2 Prostate Cancer Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Cervical Cancer
8.5.1 Cervical Cancer Market Trends Analysis (2020-2032)
8.5.2 Cervical Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Lung Cancer
8.6.1 Lung Cancer Market Trends Analysis (2020-2032)
8.6.2 Lung Cancer Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Others
8.7.1 Others Market Trends Analysis (2020-2032)
8.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Radiotherapy Market Segmentation, by End-Use
9.1 Chapter Overview
9.2 Hospitals
9.2. Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ambulatory and Radiotherapy Centers
9.3.1 Ambulatory and Radiotherapy Centers Market Trends Analysis (2020-2032)
9.3. Ambulatory and Radiotherapy Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Radiotherapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Radiotherapy Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Radiotherapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Radiotherapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Canon Medical Systems Corporation
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Types/ Services Offered
11.1.4 SWOT Analysis
11.2 Accuray Incorporated
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Types/ Services Offered
11.2.4 SWOT Analysis
11.3 Elekta
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Types/ Services Offered
11.3.4 SWOT Analysis
11.4 GE Healthcare
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Types/ Services Offered
11.4.4 SWOT Analysis
11.5 ViewRay Technologies, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Types/ Services Offered
11.5.4 SWOT Analysis
11.6 Isoray Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Types/ Services Offered
11.6.4 SWOT Analysis
11.7 Mevion Medical Systems
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Types/ Services Offered
11.7.4 SWOT Analysis
11.8 Siemens Healthineers AG
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Types/ Services Offered
11.8.4 SWOT Analysis
11.9 Hitachi, Ltd.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Types/ Services Offered
11.9.4 SWOT Analysis
11.10 ALCEN (PMB)
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Types/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiation Therapy
By Application
Skin & Lip Cancer
Breast Cancer
Prostate Cancer
Cervical Cancer
Lung Cancer
Others
By End User
Hospitals
Ambulatory and Radiotherapy Centers
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Epigenetics Market Size was valued at USD 15.2 Billion in 2023 and is expected to reach USD 66 Billion by 2032, growing at a CAGR of 17.7% over the forecast period 2024-2032.
The Wound Care Device Market Size was valued at USD 2.61 billion in 2023 and is expected to reach USD 3.94 billion by 2032 and grow at a CAGR of 4.7% over the forecast period 2024-2032.
The Breast Cancer Therapeutics Market size was valued at USD 30.22 billion in 2022 and is expected to reach USD 79.77 billion by 2030 with a growing CAGR of 12.9% over the forecast period of 2023-2030.
The Electronic Health Records (EHR) Market size, valued at USD 32.53 billion in 2023, is expected to grow up to USD 57.38 billion by 2032, registering a CAGR of 6.56% from 2024 to 2032.
The Automated Liquid Handling Technologies Market Size was valued at USD 2.11 Billion in 2023 and is expected to reach USD 5.24 Billion by 2032 and grow at a CAGR of 11.18% over the forecast period 2024-2032.
The global blood testing market was valued at USD 91.43 Bn in 2023 and is expected to reach USD 169.15 Bn by 2032, growing at a CAGR of 7.08% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
